BBI Life Sciences Competitors and Similar CompaniesClear all
BBI Life Sciences's competitors and similar companies include Cambium Bio.
 Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. | ||
Founding Date | Founding Date 2013 | Founding Date 2007 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations CN HQ | Locations Paddington, AU HQ Pymble, AU |
Employees | Employees 1,588 | Employees N/A |
Financial | ||
Revenue (est.) | Revenue (est.) ¥703.8m (FY, 2019) | Revenue (est.) $670k (FY, 2025) |
Cost of goods | Cost of goods ¥288m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit ¥417.2m (FY, 2019) | Gross profit $1.2m (FY, 2025) |
Net income | Net income ¥86m (FY, 2019) | Net income ($3.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Cambium Bio
HQ
Paddington, AU
Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.
View company